Schedule 13G ownership disclosure
KINIKSA PHARMACEUTICALS LTD
Security class unavailable · CUSIP: G5269C101
Event date: Unavailable
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 2,890,708
- Percent of class
- 8.5300%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-22-017912
- Form type
- SC 13G
- Filer
- Kiniksa Pharmaceuticals International, plc
- CIK
- CIK 1730430
- Filed
- Feb 10, 2022
- Reporting period
- —
- Description
- Schedule 13G beneficial ownership